tool.type = not a tool
is.translated = no
is.hub.landing = knowledge
is.hub.knowledge.sub-page = no
is.brand = no
Hub name = none
hub.landing-page.name = anti-clotting-medicines
Hub name = anti-clotting-medicines
Anti-clotting (antithrombotic) medicines include anticoagulant medicines (e.g. warfarin) and antiplatelet medicines (e.g. low-dose aspirin). These medicines are used to prevent and treat blood clots, but work in different ways.
You may be prescribed an anti-clotting medicine to prevent or treat blood clots if you have had a stroke or heart attack, or if you have just been diagnosed with a condition that increases your risk of blood clots and stroke — such as atrial fibrillation (an irregular heart beat). Some anti-clotting medicines are prescribed after surgery to prevent blood clots during your recovery.
Like any medicines, there are possible risks and benefits associated with anti-clotting medicines, so learning all you can about using your medicines safely and correctly will help you make any necessary adjustments to your lifestyle and get the most benefit from your medicines.
For health professionals
- The NPS Medicinewise educational program Oral anticoagulants — achieving good anticoagulant practice focusses on optimal use of warfarin and the newer oral anticoagulants dabigatran, rivaroxaban and apixaban (see program Key messages).
- The February 2013 NPS Medicinewise News discusses good anticoagulant practice, particularly use of oral anticoagulants in stroke prevention for people with non-valvular AF.
- Recent NPS RADAR articles have discussed the evidence behind use of:
— dabigatran and rivaroxaban for preventing stroke and systemic embolism in people with non-valvular AF
— dabigatran, rivaroxaban and apixaban for preventing venous thromboembolism after hip or knee replacement surgery
— rivaroxaban for treating deep venous thromboebolism.